| Patient | Hippocrates |
|---|---|
| Date of birth | 1937-01-10 |
| Identifiers | MRN HR-AC005-SYN; SSN (made up) 000-05-8153 |
| Document date | 2026-11-01 |
| Author | Eleni Vasquez-Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing care with a comprehensive geriatric assessment, after his annual wellness screening elsewhere noted slower walking and a near-fall: gait speed, Timed Up and Go, chair stands, balance, grip strength, MoCA, GDS-15, hearing, vision, nutrition and continence; frailty; a deprescribing review; bone health; what matters most to him; and a geriatric medicine consultation. Concerns: He wants to keep walking into town to teach, and to manage his stairs at home; Knee pain on stairs and on the hill, and a near-fall on his stairs that frightened him; He wants no medicine he does not need. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naproxen sodium 220 mg oral tablet, one or two tablets most days for knee pain, bought over the counter, for about two years; stopped at intake (Beers 2023: avoid chronic use) | One or two tablets by mouth up to twice a day, self-directed | Oral route | 2024-03-01 to 2026-03-02 | stopped | S |
| Diphenhydramine 25 mg oral capsule at bedtime three or four nights a week for sleep, bought over the counter; stopped at intake (Beers 2023: strongly anticholinergic) | One capsule at bedtime as needed, self-directed | Oral route | 2025-09-01 to 2026-03-02 | stopped | S |
| Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee pain, no more than 3,000 mg in a day | One to two tablets by mouth every eight hours as needed; no more than six tablets a day | Oral route | 2026-03-02 | active | S |
| Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once daily | One tablet by mouth daily | Oral route | 2026-03-02 | active | S |
| Diclofenac 1% gel, 4 g rubbed into each painful knee up to four times a day | Apply 4 g to each painful knee up to four times a day | Topical route | 2026-03-16 | active | S |
| Sodium chloride 0.65% nasal spray, two sprays in each nostril as needed for congestion | Two sprays in each nostril up to every four hours as needed | Nasal route | 2026-04-13 to 2026-04-23 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| DXA of the lumbar spine and both hips: femoral neck T-score -1.7 (lower of the two hips), total hip -1.4, lumbar spine L1 to L4 -0.6 with degenerative change; no vertebral fracture on vertebral fracture assessment | 2026-04-27 to 2026-04-27 | completed | S |
| Advance care planning conversation, about 30 minutes | 2026-06-08 to 2026-06-08 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2026-04-27 | Pneumococcal conjugate vaccine (PCV20), single dose, one or more years after PPSV23 at 65 | completed | S |
| 2026-06-08 | RSV vaccine (adjuvanted RSVpreF3), single dose for an adult aged 75 or older | completed | S |
| 2026-06-08 | Recombinant zoster vaccine, first of two doses | completed | S |
| 2026-09-28 | Recombinant zoster vaccine, second of two doses | completed | S |
| 2026-09-28 | Influenza vaccine, high-dose, trivalent, preservative-free, for this season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
No historical medical events are recorded.
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| He wants to keep walking into town to teach, and to manage his stairs at home | active | S |
| Knee pain on stairs and on the hill, and a near-fall on his stairs that frightened him | active | S |
| He wants no medicine he does not need | active | S |
Most recent measures: Sodium [Moles/volume] in Serum or Plasma 139 on 2026-03-02; Potassium [Moles/volume] in Serum or Plasma 4.4 on 2026-03-02; Creatinine [Mass/volume] in Serum or Plasma 1.08 on 2026-03-02; Glucose [Mass/volume] in Serum or Plasma 92 on 2026-03-02; Calcium [Mass/volume] in Serum or Plasma 9.3 on 2026-03-02; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 63 on 2026-03-02; Hemoglobin [Mass/volume] in Blood 13.6 on 2026-03-02; Platelets [#/volume] in Blood by Automated count 228 on 2026-03-02; Albumin [Mass/volume] in Serum or Plasma 4.1 on 2026-03-02; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 33 on 2026-06-29; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 2026-03-02; Grip strength Hand - left Dynamometer 24 on 2026-09-28; Grip strength Hand - right Dynamometer 26 on 2026-09-28; Total score [MoCA] 26 on 2026-03-02; Geriatric depression scale (GDS) short version total 2 on 2026-03-02; Total interval score [KOOSJR] 76 on 2026-09-28; Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 on 2026-09-28; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 418 on 2026-03-16; DXA Femur [T-score] Bone density -1.7 on 2026-04-27; DXA Hip [T-score] Bone density -1.4 on 2026-04-27; DXA Lumbar spine [T-score] Bone density -0.6 on 2026-04-27; Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment 11 on 2026-04-27; Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment 2.6 on 2026-04-27; Total score [Mini-Cog] 5 on 2026-06-08; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-06-08 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Slower walking, knee pain on stairs and one near-fall in the past six months, found on the comprehensive geriatric assessment at intake: gait speed 0.78 m/s, Timed Up and Go 13.8 seconds, unable to hold a tandem stance for 10 seconds, grip 24 kg; cause under evaluation with a geriatric medicine consultation | resolved | confirmed | R26.81 | S — Synthetic presenting problem of normal aging found on a comprehensive geriatric assessment; superseded at the consultation, when knee osteoarthritis with reduced leg strength and balance was diagnosed. |
| Primary osteoarthritis of both knees, diagnosed clinically by the ACR criteria (knee pain, age over 50, morning stiffness under 30 minutes, crepitus, bony enlargement, no warmth), with reduced quadriceps strength and balance and an increased risk of falls; KOOS JR 62 | active | confirmed | M17.0 | S — Synthetic modern diagnosis made at the consultation: a common, mild condition of aging chosen for a figure with no documented illness; not a claim about his real knees. |
| Potentially inappropriate over-the-counter medicines (Beers 2023): naproxen most days for about two years and diphenhydramine for sleep three or four nights a week; both stopped at intake | resolved | confirmed | Z79.1 | S — Synthetic medication history found on the deprescribing review. |
| Low bone mass (femoral neck T-score -1.7, total hip -1.4) with vitamin D insufficiency (24 ng/mL); FRAX 10-year risk 11 percent major and 2.6 percent hip, below treatment thresholds | active | confirmed | M85.89 | S — Synthetic DXA finding at eight weeks; not a claim about his real bones. |
| Common cold (viral upper respiratory infection) with runny nose, sore throat and a mild cough, no fever, chest clear, oxygen saturation 97 percent; COVID-19 and influenza tests negative; resolved in about ten days | resolved | confirmed | J06.9 | S — Synthetic acute illness; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-02 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-02 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-02 | Creatinine [Mass/volume] in Serum or Plasma | 1.08 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-03-02 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-03-02 | Calcium [Mass/volume] in Serum or Plasma | 9.3 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-03-02 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 63 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-02 | Hemoglobin [Mass/volume] in Blood | 13.6 | g/dL | 13-17 g/dL | Normal | S |
| 2026-03-02 | Platelets [#/volume] in Blood by Automated count | 228 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-03-02 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-03-02 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 24 | ng/mL | Below 20 ng/mL deficient; 20 to 29 insufficient | Low | S |
| 2026-03-02 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 2026-03-02 | Grip strength Hand - left Dynamometer | 22 | kg | S | ||
| 2026-03-02 | Grip strength Hand - right Dynamometer | 24 | kg | S | ||
| 2026-03-02 | Total score [MoCA] | 26 | {score} | S | ||
| 2026-03-02 | Geriatric depression scale (GDS) short version total | 2 | {score} | S | ||
| 2026-03-02 | Total interval score [KOOSJR] | 62 | {score} | S | ||
| 2026-03-02 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 5 | {score} | S | ||
| 2026-03-16 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 418 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-03-16 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 | {score} | S | ||
| 2026-04-27 | DXA Femur [T-score] Bone density | -1.7 | {T-score} | -1.0 or higher is normal; between -1.0 and -2.5 is low bone mass; -2.5 or lower is osteoporosis | Low | S |
| 2026-04-27 | DXA Hip [T-score] Bone density | -1.4 | {T-score} | -1.0 or higher is normal; between -1.0 and -2.5 is low bone mass; -2.5 or lower is osteoporosis | Low | S |
| 2026-04-27 | DXA Lumbar spine [T-score] Bone density | -0.6 | {T-score} | May read falsely high with spinal osteoarthritis | Normal | S |
| 2026-04-27 | Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment | 11 | % | S | ||
| 2026-04-27 | Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment | 2.6 | % | S | ||
| 2026-04-27 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S | ||
| 2026-06-08 | Total score [Mini-Cog] | 5 | {score} | S | ||
| 2026-06-08 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-06-29 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 33 | ng/mL | Below 20 ng/mL deficient; 20 to 29 insufficient | Normal | S |
| 2026-06-29 | Grip strength Hand - left Dynamometer | 24 | kg | S | ||
| 2026-06-29 | Grip strength Hand - right Dynamometer | 26 | kg | S | ||
| 2026-06-29 | Total interval score [KOOSJR] | 74 | {score} | S | ||
| 2026-06-29 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 | {score} | S | ||
| 2026-09-28 | Grip strength Hand - left Dynamometer | 24 | kg | S | ||
| 2026-09-28 | Grip strength Hand - right Dynamometer | 26 | kg | S | ||
| 2026-09-28 | Total interval score [KOOSJR] | 76 | {score} | S | ||
| 2026-09-28 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-02 | Body height | 168 | cm | S |
| 2026-03-02 | Body weight | 64.2 | kg | S |
| 2026-03-02 | Body mass index (BMI) [Ratio] | 22.7 | kg/m2 | S |
| 2026-03-02 | Systolic blood pressure | 138 | mm[Hg] | S |
| 2026-03-02 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-03-02 | Heart rate | 68 | /min | S |
| 2026-03-02 | Respiratory rate | 16 | /min | S |
| 2026-03-02 | Body temperature | 36.5 | Cel | S |
| 2026-03-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-03-16 | Body height | 168 | cm | S |
| 2026-03-16 | Body weight | 64 | kg | S |
| 2026-03-16 | Body mass index (BMI) [Ratio] | 22.7 | kg/m2 | S |
| 2026-03-16 | Systolic blood pressure | 136 | mm[Hg] | S |
| 2026-03-16 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-03-16 | Heart rate | 66 | /min | S |
| 2026-03-16 | Respiratory rate | 16 | /min | S |
| 2026-03-16 | Body temperature | 36.5 | Cel | S |
| 2026-03-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-04-13 | Body height | 168 | cm | S |
| 2026-04-13 | Body weight | 64 | kg | S |
| 2026-04-13 | Body mass index (BMI) [Ratio] | 22.7 | kg/m2 | S |
| 2026-04-13 | Systolic blood pressure | 136 | mm[Hg] | S |
| 2026-04-13 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-04-13 | Heart rate | 78 | /min | S |
| 2026-04-13 | Respiratory rate | 18 | /min | S |
| 2026-04-13 | Body temperature | 37.4 | Cel | S |
| 2026-04-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-04-27 | Body height | 168 | cm | S |
| 2026-04-27 | Body weight | 64.4 | kg | S |
| 2026-04-27 | Body mass index (BMI) [Ratio] | 22.8 | kg/m2 | S |
| 2026-04-27 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-04-27 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-04-27 | Heart rate | 66 | /min | S |
| 2026-04-27 | Respiratory rate | 16 | /min | S |
| 2026-04-27 | Body temperature | 36.4 | Cel | S |
| 2026-04-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-06-08 | Body height | 168 | cm | S |
| 2026-06-08 | Body weight | 64.5 | kg | S |
| 2026-06-08 | Body mass index (BMI) [Ratio] | 22.9 | kg/m2 | S |
| 2026-06-08 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-06-08 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-06-08 | Heart rate | 64 | /min | S |
| 2026-06-08 | Respiratory rate | 16 | /min | S |
| 2026-06-08 | Body temperature | 36.5 | Cel | S |
| 2026-06-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-06-29 | Body height | 168 | cm | S |
| 2026-06-29 | Body weight | 64.6 | kg | S |
| 2026-06-29 | Body mass index (BMI) [Ratio] | 22.9 | kg/m2 | S |
| 2026-06-29 | Systolic blood pressure | 132 | mm[Hg] | S |
| 2026-06-29 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-06-29 | Heart rate | 64 | /min | S |
| 2026-06-29 | Respiratory rate | 16 | /min | S |
| 2026-06-29 | Body temperature | 36.5 | Cel | S |
| 2026-06-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-09-28 | Body height | 168 | cm | S |
| 2026-09-28 | Body weight | 64.8 | kg | S |
| 2026-09-28 | Body mass index (BMI) [Ratio] | 23 | kg/m2 | S |
| 2026-09-28 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-09-28 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-09-28 | Heart rate | 64 | /min | S |
| 2026-09-28 | Respiratory rate | 16 | /min | S |
| 2026-09-28 | Body temperature | 36.5 | Cel | S |
| 2026-09-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-03-02 | Establishing care with a comprehensive geriatric assessment, after his annual wellness screening elsewhere noted slower walking and a near-fall: gait speed, Timed Up and Go, chair stands, balance, grip strength, MoCA, GDS-15, hearing, vision, nutrition and continence; frailty; a deprescribing review; bone health; what matters most to him; and a geriatric medicine consultation | finished | S |
| 2026-03-16 | Two-week review, seen the same day by geriatric medicine: the cause of the slower gait, knee osteoarthritis, the deprescribing plan, a strength and balance program, falls prevention and bone health | finished | S |
| 2026-04-27 | Eight-week review: knee pain and function, the strength and balance program, sleep without diphenhydramine, the DXA result and pneumococcal vaccine | finished | S |
| 2026-06-29 | Four-month review: knee function, repeat gait, balance and strength measures, vitamin D, falls and the home program | finished | S |
| 2026-09-28 | Seven-month review: knee function, mobility, falls, medicines, vaccines and what matters most to him | finished | S |
| 2026-04-13 | Same-day sick visit for a common cold | finished | S |
| 2026-06-08 | Subsequent annual wellness visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Comprehensive geriatric assessment at intake: gait speed, Timed Up and Go, 30-second chair stand, four-stage balance test, grip strength, orthostatic blood pressure, MoCA, GDS-15, hearing (whisper test), vision, nutrition (MNA-SF), continence, the Clinical Frailty Scale and the FRAIL scale; what matters most to him (4Ms) | completed | GL-IHI-4MS, GL-ICFSR-2019, GL-STEADI-2025 | S |
| Geriatric medicine consultation for slower gait and a near-fall in a man of 89: the cause, frailty, the deprescribing plan, falls prevention, bone health and a plan built on what matters most to him | completed | GL-IHI-4MS, GL-STEADI-2025, GL-WFG-2022 | S |
| Deprescribing (Beers 2023): stop over-the-counter naproxen (chronic NSAID use at 89) and diphenhydramine (strongly anticholinergic); acetaminophen up to 3,000 mg a day as needed; sleep routine without a sleep aid; check every over-the-counter purchase with the clinic or pharmacist | completed | GL-AGS-BEERS-2023 | S |
| Bone health: 25-hydroxyvitamin D at intake and after repletion; vitamin D3 1,000 units daily; calcium from food (about 1,200 mg a day); DXA of the spine and hips with FRAX | completed | GL-BHOF-2022, GL-ENDO-MEN-2012, GL-CMID-2026 | S |
| Knee osteoarthritis: diagnosis on clinical criteria without X-ray; exercise as the core treatment; diclofenac 1% gel to the knees; acetaminophen as needed; KOOS JR and a pain score at each visit; weight kept steady | completed | GL-ACR-OA-2019, GL-CMID-2026 | S |
| Falls prevention (STEADI and the World Falls Guidelines): twelve weeks of physical therapy with a progressive strength and balance program based on Otago, then tai chi twice a week; a home safety check with a second stair rail and night lights; well-fitting shoes; gait, balance and strength measures repeated after the program | completed | GL-STEADI-2025, GL-WFG-2022, GL-USPSTF-FALLS-2024 | S |
| Low bone mass below treatment thresholds (FRAX hip 2.6 percent, major 11 percent): no osteoporosis medicine now; vitamin D, dietary calcium, exercise and falls prevention; repeat DXA and FRAX in two years, or sooner after any fracture | completed | GL-BHOF-2022, GL-CMID-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Find out why he walks more slowly and nearly fell | 2026-03-16 | completed | Knee osteoarthritis with reduced quadriceps strength and balance, and diphenhydramine at night; no neurologic, thyroid, B12 or blood pressure cause | S |
| Walk into town and back for his teaching without stopping to rest, and climb his stairs safely | 2026-09-28 | completed | Gait speed 0.78 to 0.96 m/s; Timed Up and Go 13.8 to 10.9 seconds; walks to town without stopping; no falls | S |
| No medicine he does not need, and none on the Beers list | 2026-04-27 | completed | Naproxen and diphenhydramine stopped; sleeping without a sleep aid; chose not to take a cold remedy with diphenhydramine | S |
| Knee pain 3 of 10 or less on stairs | 2026-06-29 | completed | 5 to 2 of 10 on exercise, topical diclofenac and acetaminophen as needed; KOOS JR 62 to 74 | S |
| Bones and falls: vitamin D above 30 ng/mL and no falls | 2027-03-02 | active | Vitamin D 24 to 33 ng/mL; no falls in seven months | S |